The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.40
Bid: 4.12
Ask: 4.70
Change: 0.94 (27.09%)
Spread: 0.58 (14.078%)
Open: 3.64
High: 4.80
Low: 3.64
Prev. Close: 3.47
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New PREtec Products Announced

28 Sep 2023 07:00

RNS Number : 8895N
Plant Health Care PLC
28 September 2023
 

28 September 2023

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

New PREtec Products Announced

 

Brazilian Launch of MOSHY™ and TEIKKO™ planned

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce two new brands - MOSHY and TEIKKO - derived from the Company's PREtec technology platform (Vaccines for PlantsTM) for launch in Brazil for the 2024 soybean growing season.

 

Highlights:

 

· MOSHY (PHC25279) is a foliar product registered in Brazil to control foliar diseases in coffee and sugar cane.

· TEIKKO (PHC68949) is a seed treatment to control harmful soil nematodes in soybean fields. This is expected to be registered in Brazil before the end of 2023.

· MOSHY and TEIKKO add to the portfolio of Plant Health Care products available to growers in Brazil.

· Discussions with potential Brazilian distributors of MOSHY and TEIKKO are ongoing.

· For the six months ended 30 June 2023, revenue in Brazil was up 48%, driven by in-market demand for H2Copla® (Harpinαβ) and Saori® (PREtec).

 

MOSHY and TEIKKO provide specific benefits for growers of improved disease and nematode control, plant health and yield.

 

MOSHY helps control a broad spectrum of plant diseases when used as part of an integrated disease control program. MOSHY was shown to reduce the incidence and severity of sugar cane orange rust and coffee leaf rust leading to significant increases in yield. Brazil is the world's largest producer of sugar cane and coffee. As part of Plant Health Care's continued investment in Brazilian agriculture, additional crop specific, plant pathogen claims will be added to the MOSHY product label, allowing use on a wider range of crops.

 

TEIKKO is a novel product that amplifies a plant's natural defense pathways to provide protection against plant parasitic nematodes which damage plant roots and limit crop yield. TEIKKO was submitted as a seed treatment for the control of root-lesion nematode (Pratylenchus brachyurus) in soybean. Research carried out during the 2021/22 and 2022/23 soybean crop seasons showed that TEIKKO controlled Pratylenchus brachyurus in soybeans, with similar or superior performance when compared to standard market treatments. For the 2023/24 season, the soybean harvested area in Brazil is forecast to be 45.6 million hectares. Additional crops and nematode species will be added to the TEIKKO product label further expanding its potential use.

 

Both products are based on the Company's innovative PREtec technology platform. Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates plant defense and pathogen resistance mechanisms within plants, resulting in improved crop growth and quality along with the ability to withstand a variety of abiotic stresses. 

 

As well as launching new products in its existing markets, Plant Health Care continues to expand into new markets around the world and is growing its relationships with major global distribution partners. As a result, the Company is on track to achieve revenue of $30 million by 2025.

 

Jeff Tweedy, CEO of Plant Health Care, said: ‟Plant Health Care continues to scale our global business with the addition of TEIKKO and MOSHY to the Brazil product line which includes H2Copla and Saori. Plant Health Care's biological products have earned the reputation of contributing to sustainable agriculture while increasing yields, controlling diseases, and generating a positive ROI for growers. We expect MOSHY and TEIKKO to be novel biological products that will deliver control of nematodes and diseases in critical Brazil crops. These new product launches are key steps for Plant Health Care in meeting our $30 million revenue target by 2025."

 

For further information, please contact: 

Plant Health Care plc Jeff Tweedy, CEO

+1 919 926 1600

Cavendish Securities plc - Nomad & Broker Neil McDonald / Pete Lynch

+44 (0) 131 220 9771

SEC Newgate - Financial Communications Robin Tozer / Harry Handyside / George Esmond

+44 (0)7540 106 366 phc@secnewgate.co.uk

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

Find out more at www.planthealthcare.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PRLBUGDCISDDGXR
Date   Source Headline
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.